A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)

Conditions: Philadelphia-Negative ALL; Philadelphia-Positive ALL; Relapsed ALL, Adult; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Lymphoblastic Leukemia (ALL); Refractory Acute Lymphoid Leukemia in Relapse Interventions: Biological: 19-28z/IL-18 CAR T cells Sponsors: Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials